United States Indoprofen Market was valued at USD 0.40 Billion in 2022 and is projected to reach USD 0.60 Billion by 2030, growing at a CAGR of 5.20% from 2024 to 2030.
Start
Indoprofen, Once A Prominent Nonsteroidal Anti-Inflammatory Drug (Nsaid), Has Experienced A Tumultuous Journey In The U.S. Pharmaceutical Market. Initially Celebrated For Its Efficacy In Alleviating Pain And Inflammation, Its Trajectory Was Abruptly Altered Due To Unforeseen Safety Concerns.
In The 1980S, Indoprofen Was Withdrawn Globally Following Reports Of Severe Gastrointestinal Bleeding. A Comprehensive Survey Involving 6,764 Patients Revealed That Adverse Events Occurred In 22% Of Cases, With 16 Instances Of Clinically Overt Gastrointestinal Bleeding And Two Anaphylactic Reactions. This Led To Its Removal From The Market, Underscoring The Critical Importance Of Post-Marketing Surveillance In Drug Safety.
Despite Its Market Withdrawal, Indoprofen Has Continued To Pique Scientific Interest. In 2004, A High-Throughput Screening Study Discovered That Indoprofen Could Increase The Production Of The Survival Motor Neuron Protein, Offering Potential Insights Into Treatments For Spinal Muscular Atrophies. This Unexpected Finding Has Positioned Indoprofen As A Molecule Of Interest In Neurological Research, Highlighting The Serendipitous Nature Of Scientific Discovery.
Currently, The U.S. Indoprofen Market Is Primarily Research-Oriented. Leading Chemical Suppliers Such As Targetmol, Selleck Chemicals, And Toronto Research Chemicals Provide Indoprofen For Laboratory Investigations. These Companies Cater To Academic Institutions, Biotech Firms, And Pharmaceutical Companies Exploring Indoprofen'S Potential Beyond Its Original Anti-Inflammatory Purpose.
Market Analyses Indicate A Steady Demand For High-Purity Indoprofen In Research Applications. A Report From Market Research Intellect Categorizes The Market Based On Purity Levels: Min Purity Less Than 98%, Min Purity 98%-99%, And Min Purity More Than 99%. The Highest Demand Is Observed For Indoprofen With A Purity Of 98%-99%, Reflecting The Stringent Requirements Of Scientific Research.
Geographically, North America, With The U.S. At Its Core, Holds A Significant Share Of The Indoprofen Research Market. This Is Attributed To Substantial Investments In Biomedical Research And A Robust Infrastructure Supporting Drug Discovery And Development. The Region'S Focus On Innovative Therapeutic Avenues Ensures A Consistent Interest In Compounds Like Indoprofen.
However, Challenges Persist. The Historical Adverse Effects Associated With Indoprofen Necessitate Meticulous Handling And Comprehensive Safety Evaluations In Any New Research Context. Regulatory Frameworks Mandate Stringent Compliance To Ensure That Any Potential Therapeutic Applications Are Both Safe And Effective.
In Conclusion, While Indoprofen'S Journey In The U.S. Market Has Been Fraught With Challenges, Its Enduring Presence In Research Underscores The Dynamic Nature Of Pharmaceutical Sciences. The Compound'S Evolution From A Withdrawn Nsaid To A Subject Of Neurological Research Exemplifies The Ever-Evolving Landscape Of Drug Development And Repurposing.
Get an In-Depth Research Analysis of the US Indoprofen Market Size And Forecast [2025-2032]
Â
TargetMol
Selleck Chemicals
LGC
MyBiosource
AbMole
Santa Cruz Biotechnology
Toronto Research Chemicals
Merck
Biorbyt
CSNpharm
Taiclone
Aladdin
Â
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the US Indoprofen Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the US Indoprofen Market
Tablets
Liquid Suspensions
Injectable Solutions
Topical Gels
Pharmacies
Online Retailers
Hospital Pharmacies
Supermarkets and Hypermarkets
Pain Management
Anti-inflammatory Treatment
Fever Reduction
Musculoskeletal Disorders Treatment
Pediatrics
Adults
Geriatrics
Low Dose (up to 200 mg)
Moderate Dose (201 mg - 400 mg)
High Dose (above 400 mg)
US (United States, US and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Indoprofen Market Research Analysis
1. Introduction of the US Indoprofen Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. US Indoprofen Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. US Indoprofen Market, By Type
6. US Indoprofen Market, By Application
7. US Indoprofen Market, By Geography
US
Europe
Asia Pacific
Rest of the World
8. US Indoprofen Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading US Research and Consulting firm servicing over 5000+ US clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/